These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7100227

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA.
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [Abstract] [Full Text] [Related]

  • 3. Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
    Borsetti G, Rocco P, Spilimbergo PG, Giavedoni A, Frangiamone L, Beccaceci A, Judice A, Cisternino M, Volterra V.
    Pharmatherapeutica; 1984; 4(1):53-6. PubMed ID: 6150492
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
    Ahlfors UG, Dencker SJ, Gravem A, Remvig J.
    Acta Psychiatr Scand Suppl; 1980; 279():77-91. PubMed ID: 6996426
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
    Heikkilä L, Laitinen J, Vartiainen H.
    Acta Psychiatr Scand Suppl; 1981; 294():30-8. PubMed ID: 7041517
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clopenthixol decanoate in schizophrenia.
    Carney MW, Rutherford P.
    Curr Med Res Opin; 1981; 7(4):205-11. PubMed ID: 6112116
    [Abstract] [Full Text] [Related]

  • 13. [A new injectable delayed-action neuroleptic with sedative and antipsychotic action: cis-(Z)-clopenthixol decanoate. Clinical trials].
    Lambert PA, Chabannes JP.
    Encephale; 1984; 10(2):83-91. PubMed ID: 6381033
    [Abstract] [Full Text] [Related]

  • 14. [cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
    Sieberns S, Spechtmeyer H.
    Int Pharmacopsychiatry; 1982; 17(3):170-84. PubMed ID: 7141812
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A 1-year experience with the administration of clopenthixol decanoate in schizophrenic psychoses].
    Svestka J, Náhunek K, Cesková E, Rysánek R.
    Cesk Psychiatr; 1984 Jun; 80(3):146-54. PubMed ID: 6148152
    [No Abstract] [Full Text] [Related]

  • 17. The use of oral zuclopenthixol in the treatment of functional psychotic illness.
    Bereen FJ, Harte FB, Maguire J, Singh AN.
    Pharmatherapeutica; 1987 Jun; 5(1):62-8. PubMed ID: 3602024
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Findings with cis-Z-clopenthixol in the treatment of acute mania and schizophrenia.
    König P, Seifert T, Eberhardt G.
    Pharmacopsychiatry; 1986 Nov; 19(6):424-8. PubMed ID: 3797470
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.